Loading...

Rupal Shah, MD

TitleAssistant Professor
InstitutionUniversity of California San Francisco
DepartmentMedicine
Address1322-24 3rd Ave
San Francisco CA 94122
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Wayne State UniversitySchool of Medicine2005
    NYP-Columbia UniversityInternal Medicine2008
    University of PennsylvaniaPulmonary and Critical Care2012

    Collapse Overview 
    Collapse Overview
    Dr. Rupal Shah is Assistant Professor of Medicine in the Division of Pulmonary, Critical Care, Allergy and Sleep Medicine. She serves as an attending physician in the Lung Transplant Program and the Interstitial Lung Disease Program. She specializes in care of patients with advanced lung disease, both before and after lung transplantation.
    Dr. Shah received her undergraduate degree from University of Michigan, and a Masters in Clinical Epidemiology from University of Pennsylvania. She completed medical school at Wayne State University School of Medicine and did her internal medicine residency at Columbia University and advanced training in pulmonary and critical care medicine at University of Pennsylvania. She is board certified in Internal Medicine, Pulmonary Medicine, and Critical Care Medicine.


    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Singer JP, Diamond JM, Anderson MR, Katz PP, Covinsky K, Oyster M, Blue T, Soong A, Kalman L, Shrestha P, Arcasoy SM, Greenland JR, Shah L, Kukreja J, Blumenthal NP, Easthausen I, Golden JA, McBurnie A, Cantu E, Sonett J, Hays S, Robbins H, Raza K, Bacchetta M, Shah R, D'Ovidio F, Venado A, Christie JD, Lederer DJ. Frailty phenotypes and mortality after lung transplantation: A prospective cohort study. Am J Transplant. 2018 Apr 18. PMID: 29667786.
      View in: PubMed
    2. Shah R, Collard HR, Morisset J. Burden, resilience and coping in caregivers of patients with interstitial lung disease. Heart Lung. 2018 May - Jun; 47(3):264-268. PMID: 29627072.
      View in: PubMed
    3. Shah R, Diamond JM. Primary Graft Dysfunction (PGD) Following Lung Transplantation. Semin Respir Crit Care Med. 2018 Apr; 39(2):148-154. PMID: 29590671.
      View in: PubMed
    4. Kolaitis NA, Soong A, Shrestha P, Zhuo H, Neuhaus J, Katz PP, Greenland JR, Golden J, Leard LE, Shah R, Hays SR, Kukreja J, Kleinhenz ME, Blanc PD, Singer JP. Improvement in patient-reported outcomes after lung transplantation is not impacted by the use of extracorporeal membrane oxygenation as a bridge to transplantation. J Thorac Cardiovasc Surg. 2018 Feb 22. PMID: 29550072.
      View in: PubMed
    5. Porteous MK, Lee JC, Lederer DJ, Palmer SM, Cantu E, Shah R, Bellamy SL, Lama VN, Bhorade SM, Crespo MM, McDyer JF, Wille KM, Localio AR, Orens JB, Shah PD, Weinacker AB, Arcasoy S, Wilkes DS, Ware LB, Christie JD, Kawut SM, Diamond JM. Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension. Ann Am Thorac Soc. 2017 Oct; 14(10):1514-1522. PMID: 28719755.
      View in: PubMed
    6. Shah R, Diamond JM. Update in Chronic Lung Allograft Dysfunction. Clin Chest Med. 2017 Dec; 38(4):677-692. PMID: 29128018.
      View in: PubMed
    7. Winterbottom CJ, Shah R, Patterson KC, Kreider ME, Panettieri RA, Rivera-Lebron B, Miller WT, Litzky LA, Penning TM, Heinlen K, Jackson T, Localio AR, Christie JD. Exposure to Ambient Particulate Matter Is Associated With Accelerated Functional Decline in Idiopathic Pulmonary Fibrosis. Chest. 2017 Aug 09. PMID: 28802694.
      View in: PubMed
    8. Baldwin MR, Singer JP, Huang D, Sell J, Gonzalez WC, Pollack LR, Maurer MS, D'Ovidio FF, Bacchetta M, Sonett JR, Arcasoy SM, Shah L, Robbins H, Hays SR, Kukreja J, Greenland JR, Shah R, Leard L, Morrell M, Gries C, Katz PP, Christie JD, Diamond JM, Lederer DJ. Refining Low Physical Activity Measurement Improves Frailty Assessment in Advanced Lung Disease and Survivors of Critical Illness. Ann Am Thorac Soc. 2017 Aug; 14(8):1270-1279. PMID: 28398076.
      View in: PubMed
    9. Farrand E, Shah R, Collard H. The Hospitalized Patient with Interstitial Lung Disease: A Hospitalist Primer. J Hosp Med. 2017 Jul; 12(7):580-584. PMID: 28699950.
      View in: PubMed
    10. Shah R, Boin F. Lung Transplantation in Patients With Systemic Sclerosis. Curr Rheumatol Rep. 2017 May; 19(5):23. PMID: 28386760.
      View in: PubMed
    11. Singer JP, Katz PP, Soong A, Shrestha P, Huang D, Ho J, Mindo M, Greenland JR, Hays SR, Golden J, Kukreja J, Kleinhenz ME, Shah R, Blanc PD. Effect of Lung Transplantation on Health-Related Quality of Life in the Era of the Lung Allocation Score: A U.S. Prospective Cohort Study. Am J Transplant. 2017 May; 17(5):1334-1345. PMID: 27743488.
      View in: PubMed
    12. Patterson KC, Shah R, Porteous MK, Christie JD, D'Errico CA, Chadwick M, Triano MJ, Deshpande C, Rossman MD, Litzky LA, Kreider M, Miller WT. Interstitial Lung Disease in the Elderly. Chest. 2017 04; 151(4):838-844. PMID: 27865876.
      View in: PubMed
    13. Del Signore AG, Shah R, Gupta N, Altman KW, Woo P. Complications and Failures of Office-Based Endoscopic Angiolytic Laser Surgery Treatment. J Voice. 2016 Nov; 30(6):744-750. PMID: 26433447.
      View in: PubMed
    14. Adams KN, Shah R, Buckmire RA. Stricture location predicts swallowing outcomes following endoscopic rendezvous procedures. Laryngoscope. 2017 Jun; 127(6):1388-1391. PMID: 27716915.
      View in: PubMed
    15. Porteous MK, Ky B, Kirkpatrick JN, Shinohara R, Diamond JM, Shah R, Lee JC, Christie JD, Kawut SM. Diastolic Dysfunction Increases the Risk of Primary Graft Dysfunction after Lung Transplant. Am J Respir Crit Care Med. 2016 Jun 15; 193(12):1392-400. PMID: 26745666; PMCID: PMC4910888 [Available on 06/15/17].
    16. Kassutto SM, Dine CJ, Kreider M, Shah R. Changing the Ambulatory Training Paradigm. Design and Implementation of an Outpatient Pulmonology Fellowship Curriculum. Ann Am Thorac Soc. 2016 Apr; 13(4):540-4. PMID: 26862999.
      View in: PubMed
    17. Shah R, Slaughter KA, Fedore LW, Huang BY, Deal AM, Buckmire RA. Does residual wall size or technique matter in the treatment of Zenker's diverticulum? Laryngoscope. 2016 11; 126(11):2475-2479. PMID: 27010588.
      View in: PubMed
    18. Diamond JM, Porteous MK, Roberts LJ, Wickersham N, Rushefski M, Kawut SM, Shah R, Cantu E, Lederer DJ, Chatterjee S, Lama VN, Bhorade S, Crespo M, McDyer J, Wille K, Orens J, Weinacker A, Arcasoy S, Shah PD, Wilkes DS, Hage C, Palmer SM, Snyder L, Calfee CS, Ware LB, Christie JD. The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia. J Heart Lung Transplant. 2016 Apr; 35(4):500-507. PMID: 26856667; PMCID: PMC4821817 [Available on 04/01/17].
    19. Diamond JM, Shah R, Cantu E, Porteous MK, Christie JD. Survey of Lung Transplant Community's Views on Primary Graft Dysfunction. Am J Transplant. 2016 Feb; 16(2):724-6. PMID: 26743878.
      View in: PubMed
    20. Kassutto SM, Shah R. Patient Satisfaction: Why and How Patients Grade You and Your Pulmonary Practice. Chest. 2015 Sep; 148(3):833-838. PMID: 25811774.
      View in: PubMed
    21. Shah R, Diamond JM, Cantu E, Flesch J, Lee JC, Lederer DJ, Lama VN, Orens J, Weinacker A, Wilkes DS, Roe D, Bhorade S, Wille KM, Ware LB, Palmer SM, Crespo M, Demissie E, Sonnet J, Shah A, Kawut SM, Bellamy SL, Localio AR, Christie JD. Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation. Am J Transplant. 2015 Aug; 15(8):2188-96. PMID: 25877792; PMCID: PMC4721238.
    22. Singer JP, Peterson ER, Snyder ME, Katz PP, Golden JA, D'Ovidio F, Bacchetta M, Sonett JR, Kukreja J, Shah L, Robbins H, Van Horn K, Shah R, Diamond JM, Wickersham N, Sun L, Hays S, Arcasoy SM, Palmer SM, Ware LB, Christie JD, Lederer DJ. Body composition and mortality after adult lung transplantation in the United States. Am J Respir Crit Care Med. 2014 Nov 01; 190(9):1012-21. PMID: 25233138; PMCID: PMC4299586.
    23. Cantu E, Shah R, Lin W, Daye ZJ, Diamond JM, Suzuki Y, Ellis JH, Borders CF, Andah GA, Beduhn B, Meyer NJ, Ruschefski M, Aplenc R, Feng R, Christie JD. Oxidant stress regulatory genetic variation in recipients and donors contributes to risk of primary graft dysfunction after lung transplantation. J Thorac Cardiovasc Surg. 2015 Feb; 149(2):596-602. PMID: 25439478; PMCID: PMC4346512.
    24. Shah R, Emtiazjoo AM, Diamond JM, Smith PA, Roe DW, Wille KM, Orens JB, Ware LB, Weinacker A, Lama VN, Bhorade SM, Palmer SM, Crespo M, Lederer DJ, Cantu E, Eckert GJ, Christie JD, Wilkes DS. Plasma complement levels are associated with primary graft dysfunction and mortality after lung transplantation. Am J Respir Crit Care Med. 2014 Jun 15; 189(12):1564-7. PMID: 24930532; PMCID: PMC4226014.
    25. Cohen DG, Christie JD, Anderson BJ, Diamond JM, Judy RP, Shah R, Cantu E, Bellamy SL, Blumenthal NP, Demissie E, Hopkins RO, Mikkelsen ME. Cognitive function, mental health, and health-related quality of life after lung transplantation. Ann Am Thorac Soc. 2014 May; 11(4):522-30. PMID: 24605992; PMCID: PMC4225794.
    26. Diamond JM, Akimova T, Kazi A, Shah R, Cantu E, Feng R, Levine MH, Kawut SM, Meyer NJ, Lee JC, Hancock WW, Aplenc R, Ware LB, Palmer SM, Bhorade S, Lama VN, Weinacker A, Orens J, Wille K, Crespo M, Lederer DJ, Arcasoy S, Demissie E, Christie JD. Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunction. Am J Respir Crit Care Med. 2014 Mar 01; 189(5):567-75. PMID: 24467603; PMCID: PMC3977709.
    27. Shah R, Wickersham N, Lederer DJ, Palmer SM, Cantu E, Diamond JM, Kawut SM, Lama VN, Bhorade S, Crespo M, Demissie E, Sonett J, Wille K, Orens J, Weinacker A, Shah P, Arcasoy S, Wilkes DS, Christie JD, Ware LB. Preoperative plasma club (clara) cell secretory protein levels are associated with primary graft dysfunction after lung transplantation. Am J Transplant. 2014 Feb; 14(2):446-52. PMID: 24400993; PMCID: PMC3946770.
    28. Shah R, Christie JD. Response. Chest. 2014 Jan; 145(1):193. PMID: 24394844; PMCID: PMC4502758.
    29. Shah R, Diamond JM, Cantu E, Lee JC, Lederer DJ, Lama VN, Orens J, Weinacker A, Wilkes DS, Bhorade S, Wille KM, Ware LB, Palmer SM, Crespo M, Localio AR, Demissie E, Kawut SM, Bellamy SL, Christie JD. Latent class analysis identifies distinct phenotypes of primary graft dysfunction after lung transplantation. Chest. 2013 Aug; 144(2):616-622. PMID: 23429890; PMCID: PMC3734891.
    30. Shah R, Kotloff RM. Lung transplantation for obstructive lung diseases. Semin Respir Crit Care Med. 2013 Jun; 34(3):288-96. PMID: 23821504.
      View in: PubMed
    31. Cantu E, Lederer DJ, Meyer K, Milewski K, Suzuki Y, Shah R, Diamond JM, Meyer NJ, Tobias JW, Baldwin DA, Van Deerlin VM, Olthoff KM, Shaked A, Christie JD. Gene set enrichment analysis identifies key innate immune pathways in primary graft dysfunction after lung transplantation. Am J Transplant. 2013 Jul; 13(7):1898-904. PMID: 23710539; PMCID: PMC3954988.
    32. Shah R, Kotloff RM. Beware of gloved fingers. Ann Am Thorac Soc. 2013 Feb; 10(1):56-8. PMID: 23509335.
      View in: PubMed
    33. Shah R, Bellamy SL, Lee JC, Cantu E, Diamond JM, Mangalmurti N, Kawut SM, Ware LB, Christie JD. Early plasma soluble receptor for advanced glycation end-product levels are associated with bronchiolitis obliterans syndrome. Am J Transplant. 2013 Mar; 13(3):754-9. PMID: 23331756; PMCID: PMC3582806.
    34. Diamond JM, Lee JC, Kawut SM, Shah R, Localio AR, Bellamy SL, Lederer DJ, Cantu E, Kohl BA, Lama VN, Bhorade SM, Crespo M, Demissie E, Sonett J, Wille K, Orens J, Shah AS, Weinacker A, Arcasoy S, Shah PD, Wilkes DS, Ware LB, Palmer SM, Christie JD. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med. 2013 Mar 01; 187(5):527-34. PMID: 23306540; PMCID: PMC3733407.
    35. Diamond JM, Porteous MK, Cantu E, Meyer NJ, Shah R, Lederer DJ, Kawut SM, Lee J, Bellamy SL, Palmer SM, Lama VN, Bhorade SM, Crespo M, Demissie E, Wille K, Orens J, Shah PD, Weinacker A, Weill D, Arcasoy S, Wilkes DS, Ware LB, Christie JD. Elevated plasma angiopoietin-2 levels and primary graft dysfunction after lung transplantation. PLoS One. 2012; 7(12):e51932. PMID: 23284823; PMCID: PMC3526525.
    36. Shah R, Diamond JM, Lederer DJ, Arcasoy SM, Cantu EM, Demissie EJ, Kawut SM, Kohl B, Lee JC, Sonett J, Christie JD, Ware LB. Plasma monocyte chemotactic protein-1 levels at 24 hours are a biomarker of primary graft dysfunction after lung transplantation. Transl Res. 2012 Dec; 160(6):435-42. PMID: 22989614.
      View in: PubMed
    37. Diamond JM, Meyer NJ, Feng R, Rushefski M, Lederer DJ, Kawut SM, Lee JC, Cantu E, Shah R, Lama VN, Bhorade S, Crespo M, Demissie E, Sonett J, Wille K, Orens J, Weinacker A, Weill D, Arcasoy S, Shah PD, Belperio JA, Wilkes D, Ware LB, Palmer SM, Christie JD. Variation in PTX3 is associated with primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med. 2012 Sep 15; 186(6):546-52. PMID: 22822025; PMCID: PMC3480532.
    38. Shah R, Bellamy SL, Localio AR, Wickersham N, Diamond JM, Weinacker A, Lama VN, Bhorade S, Belperio JA, Crespo M, Demissie E, Kawut SM, Wille KM, Lederer DJ, Lee JC, Palmer SM, Orens J, Reynolds J, Shah A, Wilkes DS, Ware LB, Christie JD. A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation. J Heart Lung Transplant. 2012 Sep; 31(9):942-9. PMID: 22694851; PMCID: PMC3418416.